G1 Therapeutics GTHX reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
G1 Therapeutics beat estimated earnings by 9.8%, reporting an EPS of $-0.92 versus an estimate of $-1.02.
Revenue was up $3.97 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.18 which was followed by a 4.55% drop in the share price the next day.
Here's a look at G1 Therapeutics's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for G1 Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.